The Luxembourgish association, RBS – Center fir Altersfroen, has published in its latest magazine an article on the Luxembourg Parkinson Study. The article highlights how Luxembourg successfully became an internationally recognised site to investigate Parkinson’s disease.
It is important that people with Parkinson’s disease receive the optimal treatment as soon as possible to efficiently act against symptoms such as tremors and stiffness. The standard treatment includes Levodopa, a medication that replaces the dopamine. However, due to the progression of the disease over time, the medication effect gets more unstable, also related to varying levels of medication in the blood, which then causes fluctuations (dyskinesia or freezing).